DK1981506T6 - Langtidsbehandling af hiv-infektion med tcm278 - Google Patents

Langtidsbehandling af hiv-infektion med tcm278 Download PDF

Info

Publication number
DK1981506T6
DK1981506T6 DK07712053.3T DK07712053T DK1981506T6 DK 1981506 T6 DK1981506 T6 DK 1981506T6 DK 07712053 T DK07712053 T DK 07712053T DK 1981506 T6 DK1981506 T6 DK 1981506T6
Authority
DK
Denmark
Prior art keywords
tcm278
long term
hiv infection
term treatment
treatment
Prior art date
Application number
DK07712053.3T
Other languages
English (en)
Other versions
DK1981506T3 (da
Inventor
Lieven Elvire Colette Baert
Guenter Kraus
't Klooster Gerben Albert Eleutherius Van
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36446113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1981506(T6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of DK1981506T3 publication Critical patent/DK1981506T3/da
Application granted granted Critical
Publication of DK1981506T6 publication Critical patent/DK1981506T6/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07712053.3T 2006-01-20 2007-01-19 Langtidsbehandling af hiv-infektion med tcm278 DK1981506T6 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100677 2006-01-20
PCT/EP2007/050516 WO2007082922A2 (en) 2006-01-20 2007-01-19 Long term treatment of hiv- infection with tcm278

Publications (2)

Publication Number Publication Date
DK1981506T3 DK1981506T3 (da) 2013-06-24
DK1981506T6 true DK1981506T6 (da) 2021-06-14

Family

ID=36446113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07712053.3T DK1981506T6 (da) 2006-01-20 2007-01-19 Langtidsbehandling af hiv-infektion med tcm278

Country Status (27)

Country Link
US (4) US10953009B2 (da)
EP (1) EP1981506B3 (da)
JP (2) JP5754005B2 (da)
KR (2) KR101501475B1 (da)
CN (2) CN103877091A (da)
AP (1) AP2936A (da)
AR (1) AR059097A1 (da)
AU (1) AU2007206901B2 (da)
BR (1) BRPI0707179A2 (da)
CA (1) CA2636436C (da)
CY (1) CY1114089T1 (da)
DK (1) DK1981506T6 (da)
EA (1) EA014914B1 (da)
ES (1) ES2414982T7 (da)
HR (1) HRP20130544T4 (da)
IL (1) IL192132A (da)
ME (1) ME01617B (da)
MY (1) MY150717A (da)
NZ (1) NZ569347A (da)
PL (1) PL1981506T6 (da)
PT (1) PT1981506E (da)
RS (1) RS52821B2 (da)
SG (1) SG170073A1 (da)
SI (1) SI1981506T1 (da)
TW (1) TWI458483B (da)
UA (1) UA96436C2 (da)
WO (1) WO2007082922A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TW201414495A (zh) * 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
PT1981506E (pt) 2006-01-20 2013-06-25 Janssen R & D Ireland Tratamento a longo prazo da infeção pelo vih com tmc278
CN101478950B (zh) * 2006-06-23 2013-02-06 泰博特克药品有限公司 Tmc278的水性悬浮液
AU2014200819B2 (en) * 2006-06-23 2016-05-26 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
AU2016219555B2 (en) * 2006-06-23 2017-08-10 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
RU2546529C2 (ru) * 2008-12-24 2015-04-10 Тиботек Фармасьютикалз Имплантируемые устройства для лечения вич
AU2010299959B2 (en) * 2009-09-22 2016-07-21 Tibotec Pharmaceuticals Treatment and prevention of HIV infection
AU2010338425B2 (en) 2009-12-21 2015-07-23 Janssen Sciences Ireland Uc Degradable removable implant for the sustained release of an active compound
LT3494972T (lt) * 2010-01-27 2024-03-12 Viiv Healthcare Company Dolutegraviro ir lamivudino kompozicija živ infekcijai gydyti
TWI577377B (zh) * 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
US9266824B2 (en) 2014-01-13 2016-02-23 Warsaw Orthopedic, Inc. Methods and compositions for making an amino acid triisocyanate
CA3005313C (en) * 2015-11-16 2024-01-09 Evonik Rohm Gmbh Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
US20190163877A1 (en) * 2017-11-27 2019-05-30 International Business Machines Corporation Decision support for effective long-term drug therapy
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
JPH06316524A (ja) 1992-09-11 1994-11-15 Naoyuki Inoue 抗エイズウイルス剤
US6045829A (en) 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
AU7984200A (en) 1999-09-21 2001-04-24 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
BR0109602A (pt) 2000-03-30 2004-06-29 Bristol Myers Squibb Co Glóbulos de liberação controlada contendo estavudina
US20040115268A1 (en) 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
JP2005511629A (ja) 2001-11-20 2005-04-28 アドバンスト インハレーション リサーチ，インコーポレイテッド 持続作用生成物送達用組成物
US6568805B1 (en) * 2001-11-26 2003-05-27 Dan L. Dietz Trust Magnetic buckle for eyeglasses
AU2003210659A1 (en) * 2002-01-24 2003-09-02 Sangstat Medical Corporation Combination therapy for treatment of hiv infection
JP2006508134A (ja) 2002-11-08 2006-03-09 グラクソ　グループ　リミテッド 医薬組成物
WO2004046309A2 (en) 2002-11-18 2004-06-03 Phoenix Pharmacologics, Inc. Methods for inhibiting viral replication in vivo
BRPI0407329A (pt) 2003-02-07 2006-01-10 Janssen Pharmaceutica Nv Derivados de pirimidina para a prevenção de infecção de hiv
KR20050101221A (ko) 2003-02-21 2005-10-20 트리펩 아베 Ｈｉｖ 복제의 억제를 위한 글리신아미드 유도체
AU2005279158C1 (en) * 2004-09-02 2010-12-16 Janssen Pharmaceutica N.V. Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile
BRPI0514871A (pt) * 2004-09-02 2008-06-24 Janssen Pharmaceutica Nv cloridrato de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidi nil]amino] benzonitrila
CN101106972A (zh) 2004-11-16 2008-01-16 伊兰制药国际有限公司 注射用纳米微粒奥氮平制剂
TW201414495A (zh) 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
PT1981506E (pt) 2006-01-20 2013-06-25 Janssen R & D Ireland Tratamento a longo prazo da infeção pelo vih com tmc278
CN101478950B (zh) 2006-06-23 2013-02-06 泰博特克药品有限公司 Tmc278的水性悬浮液
CA2693044C (en) 2007-07-12 2017-03-14 Tibotec Pharmaceuticals Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile

Also Published As

Publication number Publication date
WO2007082922A3 (en) 2007-09-20
SG170073A1 (en) 2011-04-29
JP2013100338A (ja) 2013-05-23
US10953009B2 (en) 2021-03-23
HRP20130544T1 (en) 2013-07-31
DK1981506T3 (da) 2013-06-24
UA96436C2 (ru) 2011-11-10
EP1981506A2 (en) 2008-10-22
KR101562943B1 (ko) 2015-10-23
AU2007206901B2 (en) 2013-01-31
KR101501475B1 (ko) 2015-03-19
TWI458483B (zh) 2014-11-01
ES2414982T7 (es) 2021-11-05
WO2007082922A2 (en) 2007-07-26
NZ569347A (en) 2011-07-29
AP2936A (en) 2014-07-31
MY150717A (en) 2014-02-28
EP1981506B1 (en) 2013-03-27
US20110275654A1 (en) 2011-11-10
AP2008004535A0 (en) 2008-08-31
ES2414982T3 (es) 2013-07-23
CN103877091A (zh) 2014-06-25
SI1981506T1 (sl) 2013-08-30
BRPI0707179A2 (pt) 2011-04-26
TW200806295A (en) 2008-02-01
USRE50189E1 (en) 2024-10-29
JP2009526758A (ja) 2009-07-23
CA2636436C (en) 2014-04-01
PT1981506E (pt) 2013-06-25
EA014914B1 (ru) 2011-02-28
HRP20130544T4 (hr) 2021-08-20
JP5836983B2 (ja) 2015-12-24
HK1125828A1 (en) 2009-08-21
ME01617B (me) 2014-09-20
PL1981506T3 (pl) 2013-08-30
AR059097A1 (es) 2008-03-12
CA2636436A1 (en) 2007-07-26
IL192132A0 (en) 2009-08-03
AU2007206901A1 (en) 2007-07-26
US20240226099A1 (en) 2024-07-11
CN101370504A (zh) 2009-02-18
KR20080085194A (ko) 2008-09-23
RS52821B (sr) 2013-10-31
RS52821B2 (sr) 2021-07-30
EA200870183A1 (ru) 2009-12-30
PL1981506T6 (pl) 2021-07-12
WO2007082922A8 (en) 2008-01-03
JP5754005B2 (ja) 2015-07-22
US20210177843A1 (en) 2021-06-17
EP1981506B3 (en) 2021-06-09
CY1114089T1 (el) 2016-07-27
KR20140141699A (ko) 2014-12-10
IL192132A (en) 2014-05-28

Similar Documents

Publication Publication Date Title
DK1981506T6 (da) Langtidsbehandling af hiv-infektion med tcm278
DK1976516T3 (da) Behandling af viral hepatitis
CY2024017I1 (el) Συνδυασμοι δολουτεγραβιρης και λαμιβουδινης για την αγωγη λοιμωξης απο hiv
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DK2084174T3 (da) Fremstilling af ribofuranosylpyrimidinnukleotider
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
BRPI0820183A2 (pt) Prevenção e tratamento de infecções secundárias após infecção viral
DK2056807T3 (da) Behandling af inflammatoriske sygdomme
DK2211901T3 (da) Vaccination med multiple clader af h5-influenza-a-virus
DK2125004T3 (da) Synergistisk terapeutisk anvendelse af prothrombinkompleks koncentrater med fviii koncentrater
EP2018416A4 (en) DISPOSABLE BIOREACTOR
DK2700786T3 (da) Modifikation af overførselspassage
DK2019825T3 (da) Inhibitorer af human immundefektvirus-replikation
DK1981859T3 (da) Fremstilling af delmopinol
DK2097402T3 (da) Makrocykliske inhibitorer af hepatitis c-virus
DK2220076T3 (da) Inhibitorer af replikationen af humant immundefektvirus
DK1919904T3 (da) Makrocykliske inhibitorer af hepatitis-c-virus
DK2300560T3 (da) Termisk behandling af biomasse
DK2091673T3 (da) Elektromagnetisk behandling af kontaminerede materialer
DK2350116T3 (da) Behandling af biofilm
DK2111555T3 (da) Diagnosticering af præeklampsi
DK1732604T3 (da) Fremgangsmåder til behandling af hiv-infektion
DK2081950T3 (da) Med irinotecanbehandling forbundne ekspressionsprofiler
DK2056858T3 (da) Behandling af lungesygdomstilstande
DK1776136T3 (da) Behandling af tilstande, der involverer demyelinisering